Breaking apart condensates

Iain J McEwan* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

3 Citations (Scopus)


Prostate tumors, resistant to current antiandrogen therapies, represent a serious clinical challenge. A new report identifies androgen-receptor-dependent liquid condensates as being responsible in part for therapeutic resistance, but, encouragingly, also reveals a novel vulnerability amenable to drug targeting.
Original languageEnglish
Pages (from-to)1292-1293
Number of pages2
JournalNature Chemical Biology
Issue number12
Early online date13 Oct 2022
Publication statusPublished - Dec 2022


  • cancer therapy
  • cell signalling
  • small molecules


Dive into the research topics of 'Breaking apart condensates'. Together they form a unique fingerprint.

Cite this